MS HB1136

Limits cost-sharing obligations (copayments or coinsurance) for prescription drugs without generic equivalents to a maximum of $100.00 per one-month supply under health insurance plans and HMOs in Mississippi.

Allows annual increases to the $100.00 cap only once per year and only up to the percentage change in the medical care component of the March Consumer Price Index for Southeastern United States.

Defines "generic drug equivalent" as a drug with the same established name and active ingredients meeting applicable standards, using the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations as the basis for determination.

Applies to policies or contracts issued or delivered in Mississippi by entities regulated under Mississippi Code Chapter 9, Title 83, or health maintenance organizations.

Takes effect July 1, 2013.